Abstract

BackgroundHIV testing and serostatus awareness are essential to implement biomedical strategies (treatment as prevention; oral chemoprophylaxis), and for effective serostatus-based behaviours (HIV serosorting; strategic positioning). The analysis focuses on the associations between reported sexual risks, the perceived risk for HIV infection, and HIV testing behaviour in order to identify the most relevant barriers for HIV test uptake among MSM living in Germany.MethodsMSM were recruited to a nationwide anonymous online-survey in 2013 on MSM social networking/dating sites. Questions covered testing behaviours, reasons for testing decisions, and HIV risk perception (5-point scale). Additional questions addressed arguments in favour of home/ home collection testing (HT). Using descriptive statistics and logistic regression we compared men reporting recent HIV testing (RT; previous 12 month) with men never tested (NT) in a subsample not previously diagnosed with HIV and reporting ≥2 episodes of condomless anal intercourse (CLAI) with a non-steady partner of unknown HIV serostatus in the previous 12 months.ResultsThe subsample consisted of 775 RT (13 % of RT) and 396 NT (7 % of NT). The number of CLAI episodes in the last 12 months with non-steady partners of unknown HIV status did not differ significantly between the groups, but RT reported significantly higher numbers of partners (>5 AI partners: 65 vs. 44 %). While perceived risks regarding last AI were comparable between the groups, 49vs. 30 % NT were <30 years, lived more often in towns/villages <100,000 residents (60 vs. 39 %), were less out-particularly towards care providers-about being attracted to men (aOR 10.1; 6.9–14.8), more often identified as bisexual (aOR 3.5; 2.5–4.8), and reported lower testing intentions (aOR 0.08; 0.06–0.11).Perceived risks (67 %) and routine testing (49 %) were the most common testing reasons for RT, while the strong belief not to be infected (59 %) and various worries (41 %) and fears of testing positive (35 %) were predominant reasons of NT. Greater anonymity (aOR 3.2; 2.4–4.4), less embarrassment, (aOR 2.8; 1.9–4.1), and avoiding discussions on sexual behaviour (aOR 1.6; 1.1–2.2) were emphasized in favour of HT by NT.ConclusionsPerceived partner knowledge and reasons reflecting perceived gay- and HIV-related stigma predicted testing decisions rather than risk perception. Access barriers for testing should be further lowered, e.g. by making affordable HT available, addressing structural barriers (stigma), and emphasizing beneficial aspects of serostatus awareness.Electronic supplementary materialThe online version of this article (doi:10.1186/s12889-016-3759-5) contains supplementary material, which is available to authorized users.

Highlights

  • HIV; PrEP: (HIV); (HIV) Pre-exposure prophylaxis (PrEP): (HIV) testing and serostatus awareness are essential to implement biomedical strategies, and for effective serostatus-based behaviours (HIV serosorting; strategic positioning)

  • Questions on HIV testing and risk perception were included in the 2013 “Schwule Männer und AIDS”-Survey (SMA)-survey, as well as questions on attitudes regarding home or home collection testing, and questions on the reason to decline a free testing voucher offered to all survey participants at the end of the questionnaire

  • In the never tested (NT) group 62 % lived in a place with less than 100,000 inhabitants and almost 50 % were younger than 30 years; in the recent HIV testing (RT) group 39 % lived in a place with less than 100,000 inhabitants and 26 % were younger than 30 years

Read more

Summary

Introduction

HIV testing and serostatus awareness are essential to implement biomedical strategies (treatment as prevention; oral chemoprophylaxis), and for effective serostatus-based behaviours (HIV serosorting; strategic positioning). HIV incidence among men having sex with men (MSM) has not been declining in larger European countries with published incidence estimates [1,2,3] despite favourable “treatment cascades” (a high proportion of people diagnosed with HIV are referred into care, initiate antiretroviral treatment, and achieve undetectable viral load) for MSM reported from Western Europe [1,2,3,4,5,6,7] This is attributed to new infections occurring at a similar rate to that of diagnosis, resulting in a stable, not declining number of infected and untreated (because mostly undiagnosed) men [1].

Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call